What Impact will TrumpRx and Other DTC Programs Have on Drug Availability?

Pharmaceutical Executive: What impact will TrumpRx and other DTC programs have on drug availability?
Jesse Mendelsohn: To be clear, anything that expands access to pharmaceutical manufacturing and drugs is good. Even if this only gets several thousand people access to lifesaving drugs that previously would not have had access, that is a good thing.

The question of whether it will meaningfully expand access is a complicated question. For most people who have insurance coverage, including Medicaid or private insurance, drugs will be covered by insurance in most cases. They’ll continue to get their medications in the typical way, from...